Virios Therapeutics, Inc.
VIRI
Price:
$0.155
Market Cap:
$206.50K
Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Virios Therapeutics, LLC and changed its name to Virios Therapeutics, Inc. in December 2020. Virios Therapeutics, Inc. was founded in 2012 and i...[Read more]
Industry
Biotechnology
IPO Date
2020-12-17
Stock Exchange
NASDAQ
Ticker
VIRI
PE Ratio
[-0.03]
ROE
[-130.35%]
Current Ratio
[7.27]
Dividend Yield
[0%]
Enterprise Value
[-2813681.00]
Dividend History
The ROE as of November 2024 (TTM) for Virios Therapeutics, Inc. (VIRI) is -130.35%
According to Virios Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -130.35%. This represents a change of 280.48% compared to the average of -34.26% of the last 4 quarters.
Virios Therapeutics, Inc. (VIRI) Historical ROE (quarterly & annually)
How has VIRI ROE performed in the past?
The mean historical ROE of Virios Therapeutics, Inc. over the last ten years is -37.71%. The current -130.35% ROE has changed 245.66% with respect to the historical average. Over the past ten years (40 quarters), VIRI's ROE was at its highest in in the September 2020 quarter at 52.90%. The ROE was at its lowest in in the June 2022 quarter at -51.21%.
Average
-37.71%
Median
-72.31%
Minimum
-166.25%
Maximum
167.69%
Virios Therapeutics, Inc. (VIRI) ROE by Quarter and Year
Discovering the peaks and valleys of Virios Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 218.50%
Maximum Annual ROE = 167.69%
Minimum Annual Increase = -161.69%
Minimum Annual ROE = -166.25%
| Year | ROE | Change |
|---|---|---|
| 2023 | -139.12% | -16.32% |
| 2022 | -166.25% | 51.05% |
| 2021 | -110.06% | 218.50% |
| 2020 | -34.56% | -161.69% |
| 2019 | 56.02% | -66.59% |
Virios Therapeutics, Inc. (VIRI) Average ROE
How has VIRI ROE performed in the past?
The current ROE of Virios Therapeutics, Inc. (VIRI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-138.48%
5-year avg
-78.79%
10-year avg
-37.71%
Virios Therapeutics, Inc. (VIRI) ROE vs. Peers
How is VIRI’s ROE compared to its peers?
Virios Therapeutics, Inc.’s ROE is less than SeaStar Medical Holding Corporation (443.82%), greater than ZyVersa Therapeutics, Inc. (-25512.50%), greater than Sonnet BioTherapeutics Holdings, Inc. (-398.33%), greater than Revelation Biosciences, Inc. (-311.33%), less than eFFECTOR Therapeutics, Inc. (2.18%), greater than Zura Bio Limited (-39.61%), greater than Navidea Biopharmaceuticals, Inc. (-173.56%), greater than Immix Biopharma, Inc. (-102.10%), less than CNS Pharmaceuticals, Inc. (695.91%), less than Altamira Therapeutics Ltd. (783.37%), greater than Phio Pharmaceuticals Corp. (-134.57%), greater than TransCode Therapeutics, Inc. (-649.01%),
| Company | ROE | Market cap |
|---|---|---|
| 443.82% | $9.15M | |
| -25512.50% | $2.65M | |
| -398.33% | $2.50M | |
| -311.33% | $3.24M | |
| 2.18% | $941.00 | |
| -39.61% | $178.25M | |
| -173.56% | $100.08K | |
| -102.10% | $49.14M | |
| 695.91% | $7.15M | |
| 783.37% | $1.60M | |
| -134.57% | $2.61M | |
| -649.01% | $6.64M |
Build a custom stock screener for Virios Therapeutics, Inc. (VIRI) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Virios Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Virios Therapeutics, Inc. (VIRI) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Virios Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Virios Therapeutics, Inc.'s ROE?
How is the ROE calculated for Virios Therapeutics, Inc. (VIRI)?
What is the highest ROE for Virios Therapeutics, Inc. (VIRI)?
What is the 3-year average ROE for Virios Therapeutics, Inc. (VIRI)?
What is the 5-year average ROE for Virios Therapeutics, Inc. (VIRI)?
How does the current ROE for Virios Therapeutics, Inc. (VIRI) compare to its historical average?